Market Overview

Benzinga's Top Downgrades

Share:
Related PRXL
Jon Najarian Sees Unusual Options Activity In PAREXEL
Benzinga's Top Upgrades, Downgrades For February 6, 2017
Related MT
Earnings Scheduled For February 10, 2017
Benzinga's Top Upgrades, Downgrades For January 18, 2017

Analysts at Jefferies downgraded PAREXEL International (NASDAQ: PRXL) from “buy” to “hold.” PAREXEL's shares closed at $32.38 yesterday. PAREXEL's trailing-twelve-month ROA is 4.01%.

Analysts at Citigroup downgraded ArcelorMittal (NYSE: MT) from “buy” to “neutral.” ArcelorMittal's shares closed at $14.65 yesterday. ArcelorMittal's trailing-twelve-month profit margin is 0.69%.

Analysts at Goldman Sachs downgraded MeadWestvaco (NYSE: MWV) from “buy” to “neutral.” MeadWestvaco's shares closed at $31.20 yesterday. MeadWestvaco's PEG ratio is 2.16.

RBC Capital downgraded Endo Health Solutions (NASDAQ: ENDP) from “outperform” to “sector perform.” Endo Health's shares closed at $31.51 yesterday. Endo Health's trailing-twelve-month ROA is 5.13%.

Latest Ratings for PRXL

DateFirmActionFromTo
Feb 2017Credit SuisseDowngradesOutperformNeutral
Feb 2017Deutsche BankDowngradesHoldSell
Feb 2017CitigroupDowngradesBuyNeutral

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + MT)

View Comments and Join the Discussion!